The sensivity to insulin and therefore, dosage requirements, differs between patients with type 1-diabetes-mellitus and those with type 2-diabetes-mellitus.
Those patients with type 2-diabetes-mellitus, due to the underlying insulin resistance, will tend to require higher doses for the same reduction in BSL.
#ref
Those patients with type 2-diabetes-mellitus, due to the underlying insulin resistance, will tend to require higher doses for the same reduction in BSL.
#ref
Improve to correct grammar or spelling, but do not significantly alter the substance of the original author's text.
Cancel
Endorsed by
,
more...
Private
only
only
Dec 17, 2012
To manage hyperkalaemia: 0.1u/kg actrapid insulin IV and 2ml/kg 50% dextrose IV
Improve to correct grammar or spelling, but do not significantly alter the substance of the original author's text.
Cancel
Endorsed by
,
more...
Private
only
only
Dec 17, 2012